Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.22M Buy
79,241
+1,984
+3% +$55.7K 0.43% 85
2014
Q2
$2.18M Sell
77,257
-14,129
-15% -$403K 0.41% 83
2014
Q1
$2.79M Sell
91,386
-1,073
-1% -$32K 0.53% 72
2013
Q4
$2.69M Sell
92,459
-632
-0.7% -$18.4K 0.5% 74
2013
Q3
$2.54M Sell
93,091
-1,371
-1% -$37.3K 0.51% 76
2013
Q2
$2.51M Buy
+94,462
New +$2.61M 0.52% 70

Other funds holding PFE

Stifel Trust's PFE Position: Q3 2014 in Review

Stifel Trust increased its Pfizer (PFE) stake by 2.6% in Q3 2014, buying an estimated $55.7K and bringing the position to 79,241 shares worth $2.22M. The position accounts for 0.43% of the portfolio, ranked #85.

Stifel Trust first reported a position in PFE in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.79M in Q1 2014. 1,741 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Stifel Trust held 79,241 shares of Pfizer worth $2.22M as of Q3 2014.
  • Stifel Trust bought 1,984 Pfizer shares in Q3 2014, an estimated $55.7K.
  • Pfizer made up 0.43% of Stifel Trust's portfolio in Q3 2014, its #85 holding.
  • Stifel Trust first reported a position in Pfizer in Q2 2013 and has held it in 6 quarters since.
  • Stifel Trust's Pfizer position peaked at $2.79M in Q1 2014.
  • 1,741 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.